Biomerica, Inc. (BMRA) Set to Announce Earnings on Monday
Biomerica, Inc. (OTCMKTS:BMRA) opened at 2.6046 on Friday. The company’s market cap is $22.16 million. Biomerica, Inc. has a 1-year low of $1.53 and a 1-year high of $3.18. The company has a 50-day moving average price of $2.67 and a 200-day moving average price of $2.48.
Separately, ValuEngine downgraded shares of Biomerica from a “hold” rating to a “sell” rating in a research note on Friday, August 11th.
ILLEGAL ACTIVITY WARNING: “Biomerica, Inc. (BMRA) Set to Announce Earnings on Monday” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/26/biomerica-inc-bmra-set-to-announce-earnings-on-monday.html.
Biomerica Company Profile
Biomerica, Inc is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company’s medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores).
Receive News & Stock Ratings for Biomerica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica Inc. and related stocks with our FREE daily email newsletter.